ClinicalTrials.Veeva

Menu

Effect of Laser Acupoints on Fallopian Tube Obstruction

K

Kafrelsheikh University

Status

Enrolling

Conditions

Fallopian Tube Obstruction
Acupoints
Laser

Treatments

Other: Laser acupoints therapy + Standard care
Other: Standard care

Study type

Interventional

Funder types

Other

Identifiers

NCT07351747
KFSIRB200-711

Details and patient eligibility

About

This study aims to determine the efficacy of laser acupoint therapy on treating fallopian tube obstruction.

Full description

Fallopian tube obstruction is a significant health concern that affects a substantial number of women worldwide, often leading to infertility and other reproductive issues. The fallopian tubes, essential components of the female reproductive system, play a crucial role in the process of conception by facilitating the transport of ova from the ovaries to the uterus.

The laser's focused light energy, when directed at specific acupoints linked to reproductive health, is hypothesized to activate the body's energy pathways or meridians, thereby facilitating healing and restoration of normal tubal function.

Although acupoint therapy shows promise, laser acupoint therapy offers potential advantages over traditional acupuncture by utilizing low-level lasers, which may enhance the treatment's efficacy. Laser acupoint therapy is noninvasive and painless, making it articularly appealing for patients who have a fear of needles or are sensitive to pain.

Enrollment

36 estimated patients

Sex

Female

Ages

20 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women aged 20-35 years - nulliparous.
  • Women diagnosed with fallopian tube obstruction.
  • Body mass index less than 30 kg/m2.
  • Consent to participate in the study.
  • General good health with no major co-existing medical conditions that could interfere with the treatment or outcomes.
  • No prior fertility treatments [e.g., In vitro fertilization (IVF), intrauterine insemination (IUI)] within the last 6 months.
  • Ability to attend all scheduled sessions and follow-up assessments.

Exclusion criteria

  • Currently pregnant or breastfeeding.
  • History of pelvic surgery within the past year.
  • Presence of severe systemic diseases such as active cancer or severe cardiovascular diseases.
  • History of allergic reactions or adverse responses to acupuncture or laser therapies.
  • Currently undergoing hormonal therapy or use of hormonal contraceptives.
  • Current or recent history of genital tract infections, including sexually transmitted. infections, which could affect the reproductive system.
  • Presence of significant uterine anomalies diagnosed through imaging that could impact fertility.
  • Polycystic Ovary Syndrome (PCOS).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

36 participants in 2 patient groups, including a placebo group

Study Group (Group A)
Experimental group
Description:
Patients will receive laser acupoints therapy addition to standard care.
Treatment:
Other: Laser acupoints therapy + Standard care
Control Group (Group B)
Placebo Comparator group
Description:
Patients will receive placebo laser acupoints therapy in addition to standard care.
Treatment:
Other: Standard care

Trial contacts and locations

1

Loading...

Central trial contact

Hadeer E Shalaby, MBBCH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems